The US Food and Drug Administration has cleared sequencing-based cystic fibrosis assays, the Wall Street Journal reports.

The tests, from Illumina, include the company's MiSeqDx Cystic Fibrosis 139-Variant Assay, which examines specific spots of the CFTR gene, and its Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay, which sequences the CFTR gene and compares it to a reference, according to an FDA press release

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.